Health tech at Halfmeyer Ventures: who we back and why

Why health tech is a focus sector

Health systems still run on fragmented tools, slow handoffs, and products that ignore how clinicians and patients actually work. We back teams that turn that friction into durable software businesses: clearer workflows, better decisions, safer care paths, and commercial models that can scale without burning the company down.

We are not a specialty health fund that only writes checks and stays episodic. As a private venture studio headquartered in Berlin, we design, fund, and scale technology companies. Health tech is one of four focus sectors alongside AI, e-commerce, and automation. Many of the strongest health products we see sit at the intersection of those sectors (AI-assisted clinical tools, automated ops layers, or consumer health products with a real software moat). For the broader who-we-back profile across all sectors, see our Berlin pre-seed investor guide.

What we mean by health tech

In our practice, health tech means software-led products where the technology surface is the product, not a slide label. Strong fits include clinical and provider workflow tools, patient engagement and care coordination, digital therapeutics and remote care software, health data infrastructure with a clear buyer, and B2C health products when retention and unit economics are credible.

Adjacent verticals such as medtech, life sciences tooling, insurtech for health payers, or workplace health can fit when software, data, or automation is the core and the path to a health buyer or user is explicit. We typically pass on capital-intensive hardware-only or deep-tech bets without a software surface, pure services businesses wrapped as product, and wellness apps with no differentiated technology or credible path to durable usage. If your company sits next to health tech, explain the software surface, the buyer, any regulatory path, and traction in the deck.

Stage, ticket, and how we engage

We invest at pre-seed and seed. Our typical ticket is €25,000–€200,000. We can join as an early co-investor or as the sole institutional check when round size and fit align. Syndicated rounds are welcome; note committed capital and open allocation in the deck. Incorporation does not need to be German: UK, US (including Delaware), Swiss, and other jurisdictions work when product, market, and round structure fit.

Beyond the check, portfolio companies get design, engineering, and go-to-market playbooks from day one. That matters in health tech, where product craft, integration reality, and early commercial proof often decide whether a company compounds. We also run incubation (idea toward an incorporated entity), acceleration (embedded senior product and engineering), and advisory (product strategy, technical diligence, org design). Name the engagement model you want. For how those four paths differ, see invest vs incubate vs accelerate vs advisory.

What a strong health tech pitch shows

We look for pre-seed or seed teams with a working product, prototype, or validated problem–solution fit. Idea-only decks without validation are usually a pass for investment. Pre-revenue is common at pre-seed when there are early users, pilots, LOIs, or a clear clinical or commercial wedge. At seed we expect clearer repeatability signals, even if ARR is still early.

In the deck, make these points easy to extract:

• Buyer and workflow: who pays, who uses, and which workflow or care moment you replace or compress.
• Software surface: what the product actually does in software, data, or automation (not only the domain story).
• Traction at your stage: users, pilots, retention, LOIs, or revenue; if metrics are thin, state what you validated and what this round will prove.
• Regulatory and go-to-market reality: what constraints apply, what you have already navigated, and how you sell into health systems, providers, payers, or consumers.
• Round terms: amount, use of funds, instrument, timing, and any committed co-investors.

Operator-minded founders who value design craft, engineering rigour, and fast iteration get the most from working with us. Solo founders are welcome. First-time and repeat founders are both in scope. Our checks are dilutive equity instruments (SAFEs, convertibles, Wandeldarlehen, or priced equity); rounds that are exclusively non-dilutive with no equity tranche are not an investment fit.

Public signal from our portfolio

We publish selected portfolio names, not internals. Health-relevant names on that public list include Doctario, vi Health, Morgen Health, and Protocol Health, alongside other companies across AI, e-commerce, and automation. Public track record we state: 20+ investments, 5.6× portfolio ROI, and 100+ products built. Use those as entity facts, not as promises about your round.

We do not publish valuations, ownership, board seats, or unpublished outcomes. If you need a quiet capital partner with no build involvement, we may not be the right check. If you want a Berlin-rooted studio that can help ship product and sharpen GTM while writing €25k–€200k into health tech, you are in the right place.

How to pitch us for health tech

Submit at halfmeyer.tech/pitch. Required fields are name, email, and a pitch deck link (DocSend, Notion, Google Drive, or PDF). Company name is optional. Set the deck to view-only for anyone with the link; password walls and named invites slow review. Ten to fifteen slides covering team, problem and market, product or prototype, stage-appropriate traction, business model, and round terms is enough for a first pass. No full data room is required on first submit.

Cold submissions are welcome. You do not need a warm introduction. We review every deck personally and respond within 48 hours with a founder call path, clarifying questions by email, or a clear pass. After a productive call, diligence typically runs one to two weeks. We do not sign NDAs before initial deck review; pitch materials stay confidential and are not shared externally. State health tech fit explicitly so we can route the conversation against this thesis.

Submit your deck

If you are raising pre-seed or seed in health tech and want a Berlin venture studio that can write a meaningful early check and help you build, submit your deck. Halfmeyer Ventures responds within 48 hours.